Trial intelligence / Profile preview

Calcium Dobesilate vs Tranexamic Acid for Menorrhagia

NCT06763094Not yet recruiting

Sponsor
University of Health Sciences Lahore
Start
Jan 2025
Primary completion
Nov 2025
Modality
Small Molecules
01

Overview

Randomised, open-label trial of calcium dobesilate in Menorrhagia (2 arms), sponsored by University of Health Sciences Lahore. Primary endpoint: Pictorial Blood Loss Assessment Chart. Planned start Jan 2025; status: not yet recruiting.

02

Drugs

calcium dobesilate
03

Conditions

Menorrhagia

Beyond the preview

Go deeper on NCT06763094.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06763094.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call